VRT752271
-
Catalog numberB1679-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameVRT752271; Ulixertinib; VRT752271; VRT-752271; BVD-523; BVD523; BVD 523; N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide
-
DescriptionVRT752271 is a reversible, ATP-competitive inhibitor of ERK1 and ERK2 kinases, with IC50 of
-
CAS Number869886-67-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₂Cl₂N₄O₂
-
Molecular Weight433.33
-
Cell PermeableYes
-
Purity>98%
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA ERK1/ERK2 inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberNA
-
PubChem CID11719003
-
SMILESCC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl
-
InChiInChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1
-
InChi KeyKSERXGMCDHOLSS-LJQANCHMSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameVRT752271
-
Alternative nameVRT752271
-